All In Biotech

Drug Trial Radar · NCT04546399

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

A Phase 2 Study of Blinatumomab (NSC# 765986) in Combination With Nivolumab (NSC# 748726), a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged >/= 1 to < 31 Years Old With First Relapse

Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 461 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

461

Planned (sponsor's estimate)

Start

Dec 17, 2020

Primary completion

Jun 30, 2028

Study completion Jun 30, 2028

Sponsor

Sponsor type
NIH
First posted
Sep 14, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 1 year, up to 30 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This phase II trial studies the effect of nivolumab in combination with blinatumomab compared to blinatumomab alone in treating patients with B-cell acute lymphoblastic leukemia (B-ALL) that has come back (relapsed). Down syndrome patients with relapsed B-ALL are included in this study. Blinatumomab is an antibody, which is a protein that identifies and targets specific molecules in the body. Blinatumomab searches for and attaches itself to the cancer cell. Once attached, an immune response occurs which may kill the cancer cell. Nivolumab is a medicine that may boost a patient's immune system. Giving nivolumab in combination with blinatumomab may cause the cancer to stop growing for a period of time, and for some patients, it may lessen the symptoms, such as pain, that are caused by the cancer.

Conditions

  • Down Syndrome
  • Recurrent B Acute Lymphoblastic Leukemia

Interventions

  • 3-Dimensional Conformal Radiation TherapyRadiation

    Undergo 3D-CRT

  • Asparaginase Erwinia chrysanthemiDrug

    Given IM

  • Biospecimen CollectionProcedure

    Undergo blood, urine and cerebrospinal fluid collection

  • BlinatumomabBiological

    Given IV

  • Bone Marrow AspirationProcedure

    Undergo bone marrow aspiration

  • Bone Marrow BiopsyProcedure

    Undergo bone marrow biopsy

  • Calaspargase PegolDrug

    Given IV

  • CytarabineDrug

    Given IT

  • DexamethasoneDrug

    Given PO or IV

  • Hydrocortisone Sodium SuccinateDrug

    Given IT

  • Lumbar PunctureProcedure

    Undergo lumbar puncture

  • MercaptopurineDrug

    Given PO

  • MethotrexateDrug

    Given IT, PO, and IV

  • NivolumabBiological

    Given IV

  • PegaspargaseDrug

    Given IM or IV

  • Vincristine SulfateDrug

    Given IV push or via infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Minimal residual disease (MRD) negative second remission (Rem-2) rate with blinatumomab vs with blinatumomab + nivolumab (Group 1)Time frame: Up to 2 cycles of therapy (each cycle = 36 days)
  2. Event-free survival post-reinduction (EFS PR) (Group 3)Time frame: From date of randomization to date of treatment failure, relapse, second malignancy (SMN) or death due to any cause, assessed up to 10 years after completion of enrollment.
  3. EFS PR (Group 4)Time frame: From date of randomization to date of treatment failure, relapse, second malignancy (SMN) or death due to any cause, assessed up to 10 years after completion of enrollment.

Locations

229 sites in 4 countries. Site status is shown where the registry gives one.

  • Children's Hospital of Alabama

    Birmingham, Alabama · Recruiting

  • USA Health Strada Patient Care Center

    Mobile, Alabama · Recruiting

  • Providence Alaska Medical Center

    Anchorage, Alaska · Recruiting

  • Kingman Regional Medical Center

    Kingman, Arizona · Suspended

  • Banner Children's at Desert

    Mesa, Arizona · Recruiting

  • Phoenix Childrens Hospital

    Phoenix, Arizona · Recruiting

  • Banner University Medical Center - Tucson

    Tucson, Arizona · Recruiting

  • Arkansas Children's Hospital

    Little Rock, Arkansas · Recruiting

  • Kaiser Permanente-Anaheim

    Anaheim, California · Suspended

  • PCR Oncology

    Arroyo Grande, California · Suspended

  • Kaiser Permanente-Bellflower

    Bellflower, California · Suspended

  • Kaiser Permanente Downey Medical Center

    Downey, California · Recruiting

  • City of Hope Comprehensive Cancer Center

    Duarte, California · Active not recruiting

  • Kaiser Permanente-Fontana

    Fontana, California · Recruiting

  • Loma Linda University Medical Center

    Loma Linda, California · Recruiting

  • Miller Children's and Women's Hospital Long Beach

    Long Beach, California · Recruiting

  • Children's Hospital Los Angeles

    Los Angeles, California · Recruiting

  • Kaiser Permanente Los Angeles Medical Center

    Los Angeles, California · Suspended

  • Cedars-Sinai Medical Center

    Los Angeles, California · Recruiting

  • Mattel Children's Hospital UCLA

    Los Angeles, California · Recruiting

  • Valley Children's Hospital

    Madera, California · Recruiting

  • Kaiser Permanente-Oakland

    Oakland, California · Recruiting

  • Children's Hospital of Orange County

    Orange, California · Recruiting

  • Lucile Packard Children's Hospital Stanford University

    Palo Alto, California · Recruiting

  • Sutter Medical Center Sacramento

    Sacramento, California · Recruiting

  • University of California Davis Comprehensive Cancer Center

    Sacramento, California · Recruiting

  • Kaiser Permanente-San Diego Zion

    San Diego, California · Recruiting

  • Rady Children's Hospital - San Diego

    San Diego, California · Recruiting

  • UCSF Medical Center-Mission Bay

    San Francisco, California · Recruiting

  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

    Torrance, California · Active not recruiting

  • Children's Hospital Colorado

    Aurora, Colorado · Recruiting

  • Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center

    Denver, Colorado · Recruiting

  • Connecticut Children's Medical Center

    Hartford, Connecticut · Recruiting

  • Alfred I duPont Hospital for Children

    Wilmington, Delaware · Recruiting

  • MedStar Georgetown University Hospital

    Washington D.C., District of Columbia · Recruiting

  • Children's National Medical Center

    Washington D.C., District of Columbia · Recruiting

  • Golisano Children's Hospital of Southwest Florida

    Fort Myers, Florida · Recruiting

  • UF Health Cancer Institute - Gainesville

    Gainesville, Florida · Recruiting

  • Memorial Regional Hospital/Joe DiMaggio Children's Hospital

    Hollywood, Florida · Recruiting

  • Nemours Children's Clinic-Jacksonville

    Jacksonville, Florida · Recruiting

Showing 40 of 229 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.